Physician profile
Brian M Culp
NPI 1750693909
$382,049.51
in general payments reported to CMS, 2019-2025
21 companies · $61K in 2025
The $61K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $25K · 2021: $45K · 2022: $44K · 2023: $80K · 2024: $98K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $206K · Travel and Lodging: $26K · Food and Beverage: $6,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $205,744.76 |
| Travel and Lodging | $26,163.72 |
| Food and Beverage | $6,619.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $286,692.72 | 2019-2025 | Gmk Sphere, Amistem, Moto Uni |
| Ethicon US, LLC | $25,965.56 | 2019-2025 | Stratafix, Dermabond Prineo, Dermabond |
| Medical Device Business Services, INC. | $22,801.35 | 2019-2024 | Stratafix, Dermabond Prineo, Dermabond |
| Intellijoint Surgical INC. | $21,567.32 | 2019-2024 | Intellijoint Hip, Intelljoint |
| Ethicon INC. | $10,631.20 | 2021-2023 | Dermabond |
| Smith+Nephew, INC. | $8,555.69 | 2019-2025 | Pico 14, Renasys Touch |
| Depuy Synthes Sales INC. | $3,398.74 | 2019-2023 | Attune, Velys, Na |
| Zimmer Biomet Holdings, INC. | $678.36 | 2019-2025 | G7 |
| Stryker Corporation | $314.07 | 2019-2025 | Tritanium, Trident, Mako |
| Nextstep Arthropedix, LLC | $252.88 | 2021-2022 | |
| Baxter Healthcare | $251.25 | 2023 | Floseal |
| Pacira Therapeutics, INC. | $235.41 | 2019-2021 | |
| Innovation Technologies INC | $150.90 | 2024 | Irrisept |
| Davol INC. | $127.06 | 2024 | Channel Drain |
| Heraeus Medical, LLC. | $124.09 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $99.12 | 2023 | Prevena |
| Next Science LLC | $68.74 | 2023 | Xperience, Blastx, Surgx |
| Bioventus LLC | $50.85 | 2019-2021 | |
| Medtronic, INC. | $41.51 | 2022 | |
| Ferring Pharmaceuticals INC. | $27.12 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $15.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$15,652.86 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Culp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.